Why The Biggest IPO In Biotech History Could Have A 'Disruptive' Impact

Why The Biggest IPO In Biotech History Could Have A 'Disruptive' Impact

Source: 
Investors Business Daily
snippet: 

Moderna stock popped Friday after an analyst rated it a buy, saying the biotech could launch a "disruptive class of medicines."